Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

Author： Dell’Osso Bernardo Allen Andrea Hollander Eric

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.15, 2005-12, pp. : 2727-2740

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

By Shoja Shafti Saeed

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Treating obsessive-compulsive disorder with serotonin reuptake inhibitors

By Koran L.M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 162-163

Elsevier

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

By Silver Henry

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2053-2058

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence

By Zinner Norman R

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite